Further to their role in the immune system, MLKL activity and necroptosis have also been implicated in the pathogenesis of a range of other clinical conditions, including neurodegenerative diseases such as amyotrophic lateral sclerosis, Alzheimer’s disease, and multiple sclerosis15–18. This evidence concerns the gene MLKL and early-onset autosomal dominant Alzheimer disease.